| Abstract: | This paper describes a fully automated on-line method combining in-tube solid-phase microextraction (SPME) in which sample
clean-up and enrichment are conducted through an open tubular fused-silica capillary column and high-performance liquid chromatography
(HPLC)/tandem mass spectrometry (MS/MS) detection for the determination of six butyrophenone derivatives (moperone, floropipamide,
haloperidol, spiroperidol, bromperidol, and pimozide) in human plasma samples. The six butyrophenones were extracted by repeatedly
aspirating and dispensing plasma sample solutions on a DB-17 capillary column (60 cm × 0.32 mm i.d., film thickness 0.25 μm).
The analytes retained on the inner surface of the capillary column were then eluted into an acetonitrile-rich mobile phase
using a gradient separation technique. Extraction efficiencies ranged from 12.7% to 31.8% for moperone, spiroperidol, and
pimozide, and from 1.08% to 4.86% for floropipamide, haloperidol, and bromperidol. The regression equations for all compounds
showed excellent linearity, ranging from 0.05 to 50 ng/0.1 mL of plasma, except for moperone and spiroperidol (0.01 to 50 ng/0.1 mL).
The limits of detection and quantification in plasma for each drug were 0.03–0.2 and 0.1–0.5 ng/mL, respectively. The intra-
and inter-day coefficients of variation for all compounds in plasma were not greater than 13.7%. |
